Mirati Therapeutics, Inc.
NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

Last updated:

Abstract:

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

21 Apr 2020

Issue date:

7 Jul 2022